(Radio)Theranostic Patient Management in Oncology Exemplified by Neuroendocrine Neoplasms, Prostate Cancer, and Breast Cancer
作者： Irina Velikyan
DOI: 10.3390/PH13030039
关键词: Oncology 、 Patient management 、 Personalized medicine 、 Internal medicine 、 MEDLINE 、 Breast cancer 、 Context (language use) 、 Prostate cancer 、 Medicine
摘要: The role of nuclear medicine in the management oncological patients has expanded during last two decades. number radiopharmaceuticals contributing to realization theranostics/radiotheranostics context personalized is increasing. This review focused on examples targeted (radio)pharmaceuticals for imaging and therapy neuroendocrine neoplasms (NENs), prostate cancer, breast cancer. These strongly demonstrate tendency development towards medicine.
mdpi.com
sci-hub.se 参考文章(184)
Deborah Pencharz, Gopinath Gnanasegaran, Shaunak Navalkissoor, Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy. British Journal of Radiology. ,vol. 91, pp. 20180108- ,(2018) , 10.1259/BJR.20180108
Pim J. van Leeuwen, Maarten Donswijk, Rohan Nandurkar, Phillip Stricker, Bao Ho, Stijn Heijmink, Esther M.K. Wit, Corinne Tillier, Erik van Muilenkom, Quoc Nguyen, Henk G. van der Poel, Louise Emmett, Gallium‐68‐prostate‐specific membrane antigen (68Ga‐PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate‐ and high‐risk prostate cancer BJUI. ,vol. 124, pp. 62- 68 ,(2019) , 10.1111/BJU.14506
Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller, Richard P. Baum, Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients. The Journal of Nuclear Medicine. ,vol. 60, pp. 377- 385 ,(2019) , 10.2967/JNUMED.118.215848
Simron Singh, Raymond Poon, Rebecca Wong, Ur Metser, 68Ga PET Imaging in Patients With Neuroendocrine Tumors: A Systematic Review and Meta-analysis. Clinical Nuclear Medicine. ,vol. 43, pp. 802- 810 ,(2018) , 10.1097/RLU.0000000000002276
Ahmed Eissa, Ahmed Elsherbiny, Rafael F. Coelho, Jens Rassweiler, John W. Davis, Francesco Porpiglia, Vipul R. Patel, Napoleone Prandini, Salvatore Micali, Maria Chiara Sighinolfi, Stefano Puliatti, Bernardo Rocco, Giampaolo Bianchi, The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature. The Italian journal of urology and nephrology. ,vol. 70, pp. 462- 478 ,(2018) , 10.23736/S0393-2249.18.03081-3
Mustapha El Lakis, Andreas Gianakou, Pavel Nockel, Douglas Wiseman, Amit Tirosh, Martha A. Quezado, Dhaval Patel, Naris Nilubol, Karel Pacak, Samira M. Sadowski, Electron Kebebew, Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors. JAMA Surgery. ,vol. 154, pp. 40- 45 ,(2019) , 10.1001/JAMASURG.2018.3475
Louise Emmett, Megan Crumbaker, Bao Ho, Kathy Willowson, Peter Eu, Lalith Ratnayake, Richard Epstein, Ashley Blanksby, Lisa Horvath, Alex Guminski, Kate Mahon, Craig Gedye, Charlotte Yin, Phillip Stricker, Anthony M. Joshua, Results of a Prospective Phase 2 Pilot Trial of 177Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression. Clinical Genitourinary Cancer. ,vol. 17, pp. 15- 22 ,(2019) , 10.1016/J.CLGC.2018.09.014
J. Ohnona, V. Nataf, M. Gauthé, S. Balogova, O. Bélissant Benesty, J. Zhang-Yin, J-N. Talbot, F. Montravers, Prognostic value of functional tumor burden on 68Ga-DOTATOC PET/CT in patients with pancreatic neuro-endocrine tumors. Neoplasma. ,vol. 66, pp. 140- 148 ,(2019) , 10.4149/NEO_2018_180328N209
Pieter J.L. De Visschere, Chloë Standaert, Jurgen J. Fütterer, Geert M. Villeirs, Valeria Panebianco, Jochen Walz, Tobias Maurer, Boris A. Hadaschik, Frédéric E. Lecouvet, Gianluca Giannarini, Stefano Fanti, A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer European Urology Oncology. ,vol. 2, pp. 47- 76 ,(2019) , 10.1016/J.EUO.2018.09.010
Matthias M. Heck, Robert Tauber, Sebastian Schwaiger, Margitta Retz, Calogero D’Alessandria, Tobias Maurer, Andrei Gafita, Hans-Jürgen Wester, Jürgen E. Gschwend, Wolfgang A. Weber, Markus Schwaiger, Karina Knorr, Matthias Eiber, Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer. European Urology. ,vol. 75, pp. 920- 926 ,(2019) , 10.1016/J.EURURO.2018.11.016